Alnylam Pharmace. buy Stifel Nicolaus
Summary
This prediction ended on 15.09.24 with a price of €240.20. The BUY prediction by Stifel_Nicolaus for Alnylam Pharmace. saw massive gains of 32.41%. Stifel_Nicolaus has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Stifel_Nicolaus has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Alnylam Pharmace. | 2.962% | 2.962% | 52.306% |
iShares Core DAX® | -0.693% | 2.143% | 24.303% |
iShares Nasdaq 100 | -1.173% | 1.632% | 12.915% |
iShares Nikkei 225® | -1.388% | 2.138% | 7.771% |
iShares S&P 500 | -1.411% | 0.648% | 7.222% |
Comments by Stifel_Nicolaus for this prediction
In the thread Alnylam Pharmace. diskutieren
In the thread Trading Alnylam Pharmace.
Current prediction by Stifel_Nicolaus for Alnylam Pharmace.
Alnylam Pharmace.
31.03.25
31.03.26
10.10.25
Stopped prediction by Stifel_Nicolaus for Alnylam Pharmace.
Alnylam Pharmace.
06.10.25
06.10.26
10.10.25
Alnylam Pharmace.
27.06.24
27.06.25
28.06.25